Home   »   Biovigilance
Top Performing

Biovigilance Programme of India: Objectives, Features and Significance

The Government of India has approved the Biovigilance Programme of India to strengthen the monitoring and prevention of adverse events associated with products used in organ and tissue transplantation.

The programme aims to create a systematic framework for ensuring the safety of both transplant donors and recipients.

What is the Biovigilance Programme of India?

  • It is a national surveillance programme focused on the safety of products used in transplantation.
  • It will monitor adverse events associated with medicines and biological products.
  • The programme will cover products administered to both donors and recipients.
  • It will involve systematic reporting, assessment, monitoring, and prevention of adverse events.
  • The Indian Pharmacopoeia Commission (IPC) will play a key coordinating role.

Key Features

1. Transplant Safety

The programme will track and assess adverse events associated with medicines and biological products used during organ and tissue transplantation.

2. Donor and Recipient Coverage

Biological products administered to both transplant donors and recipients will come under the safety-monitoring framework.

3. Role of Indian Pharmacopoeia Commission

The IPC will coordinate activities related to:

  • Adverse-event reporting
  • Assessment and evaluation
  • Safety monitoring
  • Prevention and risk reduction

4. Integrated Pharmacovigilance

The programme will complement India’s existing safety-monitoring mechanisms:

Programme Focus
Biovigilance Programme of India Safety of biological products used in transplantation
PvPI Adverse drug reactions
MvPI Medical-device-related adverse events

Why is Biovigilance Important?

Organ transplantation involves complex medical procedures and the use of medicines and biological products that can potentially cause adverse events.

A dedicated biovigilance framework can help:

  • Detect safety signals at an early stage
  • Improve reporting of adverse events
  • Strengthen evidence-based safety assessment
  • Reduce preventable risks
  • Improve patient and donor safety
  • Support safer transplantation practices

Biovigilance Programme of India: Objectives, Features and Significance_3.1

UPSC IAS Live GS P2I Foundation 2027 Pratigya September Batch (Basic)

Sharing is caring!